Executive Summary

Personalised medicine and artificial intelligence (AI) offer significant potential to improve patient outcomes in the NHS through earlier diagnosis, more precise prescribing and more efficient care pathways. Advances in genomics, pharmacogenomics and AI enabled diagnostics means that these approaches are increasingly ready for wider clinical application. However, their implementation within routine care remains limited.

​

This report prepared by Global Policy Network, draws on evidence from Roundtable 4(Genomics and AI) and Roundtable 5 (Medicines Optimisation and Digital Infrastructure), alongside wider policy and academic research. It identifies that the primary barrier to realising the benefits of personalised medicine and AI is structural fragmentation across NHS data systems and service design.